Female representation over to more senior stages of a medical career suffers from a “leaky pipeline”. A major factor in this is the time taken out to raise children but there are practical interventions that can be implemented and biases than need overturning.

Not all ST-elevations are created equal. Trainees would benefit from considering a broader number of causes for this presentation.

Taking long breaks from medicine for can lead to loss of skills and confidence. Simulation training is an effective way to brush off the cobwebs before returning to practice.

A 74-year-old male presents with shortness of breath less than two weeks after AF ablation. This discussion gives an update of technological interventions for atrial fibrillation and their risks.

Medical schools in Aotearoa-New Zealand have turbocharged their intake of Māori and Pasifika students but these graduates have not trickled through to the RACP’s training programs in great numbers. We take a look at the culture of training environments and also the recent politicking over Māori self-governance.

52-year-old female presenting with clumsiness and paresthesia of the right hand had three weeks prior undergone a suboccipital craniotomy for a Chiari malformation. She had accompanying headaches, but there was a past medical history of migraines and a family history of a Factor V Leiden mutation.

Professor Gary Lee established the first dedicated pleural service in the southern hemisphere in 2009. In this podcast he summarises key developments in the management of pleural disease over the last thirty years.

A 42-year-old male transplant patient experiences a devastating fever. His treating clinicians discuss the tangled diagnostic considerations for an immunosuppressed patient.

Tissue-agnostic therapies may be a godsend for people with rare cancers and cancers of unknown origin, but regulatory and funding frameworks haven’t kept up with the scientific revolution.

Genomics has allowed increasingly rapid development highly-targeted cancer drugs and unprecedented improvements in outcomes for patients with more common cancers. Now, patients with rare cancers also have some hope in the form of tissue-agnostic therapies.